Search

everythinglearnresearchcommunity

for

Search:↓

Cyproterone acetate effectively reduced hair growth in hirsute patients by lowering androgen levels and altering androgen metabolism.

Different substances that activate or block the androgen receptor can affect male development and treat conditions like prostate cancer.

The patient's high testosterone was reduced by a medication that suppresses gonadotropin.

The study developed methods to measure biomarkers in mice and found differences in hormone levels linked to gut microbiota diversity and stress response.

Researchers found new potential treatments for conditions related to the androgen receptor, like male hormonal contraception, by testing thousands of compounds.

Spironolactone effectively reduces hair growth in women with hirsutism and is generally well-tolerated.

Deslorelin implant successfully regrew hair in a female Pomeranian with alopecia X.

Lithocholic acid helps hair growth and regeneration in alopecia by activating vitamin D receptors.

Hormone replacement therapy may improve hair growth in the frontal hairline of postmenopausal women with hair loss.

Allopregnanolone and opioids together reduce stress hormone responses during pregnancy.

Non-binary transgender individuals need personalized hormonal treatments for better well-being and quality of life.

A new topical treatment for hair loss shows promise by targeting androgen receptors.

Hormone therapy might be a proactive alternative to watchful waiting for early-stage prostate cancer, potentially improving survival without aggressive treatment downsides.

Antibody treatments show promise for hair loss but need more research.

The nature of the side chain in RU 58841 derivatives greatly affects its AR affinity, with the N-(iodopropenyl) derivative 13 showing the highest AR binding affinity, suggesting its potential for developing high-affinity radioiodinated AR radioligands.

Antiandrogens, particularly flutamide and CPA, are most effective for treating hirsutism, with long-term use needed for best results.

Hormonal therapies can improve skin issues by adjusting hormone levels, with future advancements promising better results.

Combining light therapy with certain substances improves hair growth in people with hair loss.

Low-level light therapy can safely and effectively stimulate hair growth in people with androgenetic alopecia.

Goserelin injections can effectively manage hyperandrogenism symptoms in postmenopausal women who can't have surgery.

The treatment significantly reduced hair growth and male hormone levels in hirsute women.

Scientists created iodinated arylhydantoins and arylthiohydantoins that could potentially be used for imaging prostate cancer. Some versions with specific side-chains showed high potential for this use.

The study found that imaging might miss small ovarian tumors causing high testosterone, and suggested using certain testosterone levels and treatment responses to identify these tumors.

Aryl hydrocarbon receptor overexpression found in miniaturized hair follicles in female hair loss.

AR-27 E-Chol siRNA can effectively promote hair regrowth for androgenetic alopecia.

Hormonal therapies might help treat hidradenitis suppurativa, but treatment is complex and personalized.

Elevated luteinizing hormone contributes to female-pattern hair loss, and blocking certain channels may help prevent it.

Scientists have developed a new method to detect steroid abuse in athletes using cell-based tests, which could be the future of anti-doping methods.

All three treatments reduce hirsutism, but spironolactone works best long-term.

GLP-1 agonists may help treat certain skin conditions.